Janagliflozin

Overview

Janagliflozin is orally active and highly selective sodium-glucose cotransporter 2 ( SGLT2 ) inhibitor ( IC 50 =0.0058 μM for SGLT2 and 4.802 μM for SGLT1 ). Janagliflozin inhibits SGLT2 in the proximal renal tubules, reducing glucose reabsorption and promoting urinary glucose excretion (UGE) to lower blood glucose levels. Janagliflozin is promising for research of type 2 diabetes mellitus.

Application

Products | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT

Product Information

• Catalog No.: HY-178734
• CAS No.: 1800115-22-3
• Molecular Formula: C25H29ClO6
• Molecular Weight: 460.95
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source